Literature DB >> 3128481

Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).

R D Martinez1, T D Wilkins.   

Abstract

Hemorrhagic toxin (toxin HT) was purified from Clostridium sordellii culture filtrate. The purification steps included ultrafiltration through an XM-100 membrane filter and immunoaffinity chromatography, using a monoclonal antibody to toxin A of Clostridium difficile as the ligand. Toxin HT migrated as a major band with a molecular weight of 525,000 and a minor band at 450,000 on nondenaturing gradient polyacrylamide gel electrophoresis. The molecular weight was estimated at 300,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Isoelectric focusing indicated an apparent pI of 6.1. Toxin HT was cytotoxic for cultured cells and lethal for mice by intraperitoneal injection, and it elicited an accumulation of hemorrhagic fluid in rabbit ileal loops. Immunodiffusion analysis revealed a reaction of partial identity between toxins A and HT. Immunological cross-reactivity between these toxins was further demonstrated by immunoblotting and by neutralization of toxin HT biological activity with antibodies to toxin A. A sensitive indirect enzyme-linked immunosorbent assay was used to examine the affinity involved in homologous and heterologous antigen-antibody interactions. Our findings show that toxin HT has biological activities and immunological properties similar to those of toxin A; however, the toxins are not identical.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128481      PMCID: PMC259787          DOI: 10.1128/iai.56.5.1215-1221.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  The toxins responsible for the lesions of Clostridium sordelli gas gangrene.

Authors:  S N Arseculeratne; R G Panabokké; S Wijesundera
Journal:  J Med Microbiol       Date:  1969-02       Impact factor: 2.472

Review 3.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 4.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

5.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

6.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

7.  Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

Authors:  T W Chang; S L Gorbach; J B Bartlett
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

8.  Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin.

Authors:  M Allo; J Silva; R Fekety; G D Rifkin; H Waskin
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

9.  Pseudomembranous colitis: Presence of clostridial toxin.

Authors:  H E Larson; A B Price
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

10.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

View more
  22 in total

1.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.

Authors:  S M Frey; T D Wilkins
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Comparative analysis of the extracellular proteomes of two Clostridium sordellii strains exhibiting contrasting virulence.

Authors:  Maureen T Kachman; Mary C Hurley; Teri Thiele; Geetha Srinivas; David M Aronoff
Journal:  Anaerobe       Date:  2010-03-23       Impact factor: 3.331

Review 3.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 4.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

5.  Development and evaluation of a PCR method for detection of the Clostridium difficile toxin B gene in stool specimens.

Authors:  C Guilbault; A-C Labbé; L Poirier; L Busque; C Béliveau; M Laverdière
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Purification and characterization of alpha-toxin produced by Clostridium novyi type A.

Authors:  D W Ball; R L Van Tassell; M D Roberts; P E Hahn; D M Lyerly; T D Wilkins
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

7.  Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile.

Authors:  F Hofmann; A Herrmann; E Habermann; C von Eichel-Streiber
Journal:  Mol Gen Genet       Date:  1995-06-25

Review 8.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

9.  Identification and characterization of Clostridium sordellii toxin gene regulator.

Authors:  Apoorva Reddy Sirigi Reddy; Brintha Parasumanna Girinathan; Ryan Zapotocny; Revathi Govind
Journal:  J Bacteriol       Date:  2013-07-19       Impact factor: 3.490

10.  A rare case of Clostridium sordellii bacteremia in an immunocompromised patient.

Authors:  J Matten; V Buechner; R Schwarz
Journal:  Infection       Date:  2009-04-23       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.